Cargando…

Clinical significance and association of RUNX3 hypermethylation frequency with colorectal cancer: a meta-analysis

BACKGROUND: The RUNX family, which is composed of RUNX1, RUNX2, and RUNX3, is a sequence-specific transcription factor family and is closely involved in a variety of cellular processes including development, differentiation, participation in the regulation of p53-dependent DNA damage response and/or...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mu, Wei-Ping, Wang, Jian, Niu, Qiong, Shi, Ning, Lian, Hai-Feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2014
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4105273/ https://www.ncbi.nlm.nih.gov/pubmed/25053885 http://dx.doi.org/10.2147/OTT.S62103

Ejemplares similares

The clinicopathological significance of RUNX3 hypermethylation and mRNA expression in human breast cancer, a meta-analysis
por: Song, Xiao-yun, et al.
Publicado: (2016)

An early biomarker and potential therapeutic target of RUNX 3 hypermethylation in breast cancer, a system review and meta-analysis
por: Lu, De-guo, et al.
Publicado: (2016)

Downregulation of the RUNX3 Gene by Promoter Hypermethylation and Hemizygous Deletion in Breast Cancer
por: Hwang, Ki-Tae, et al.
Publicado: (2007)

Clinical significance of DAPK promoter hypermethylation in lung cancer: a meta-analysis
por: Li, Ying, et al.
Publicado: (2015)

Clinicopathological Significance of CDKN2A Promoter Hypermethylation Frequency with Pancreatic Cancer
por: Tang, Bo, et al.
Publicado: (2015)

Clinicopathological significance of p15 promoter hypermethylation in multiple myeloma: a meta-analysis
por: Wei, Bing, et al.
Publicado: (2016)

The frequency of promoter DNA hypermethylation is decreased in colorectal neoplasms of familial adenomatous polyposis
por: Takane, Kiyoko, et al.
Publicado: (2018)

Hypermethylation of APC2 Is a Predictive Epigenetic Biomarker for Chinese Colorectal Cancer
por: He, Yuan, et al.
Publicado: (2018)

RUNX1/CEBPA Mutation in Acute Myeloid Leukemia Promotes Hypermethylation and Indicates for Demethylation Therapy
por: Romanova, Ekaterina I., et al.
Publicado: (2022)

The clinicopathological significance of FHIT hypermethylation in non-small cell lung cancer, a meta-analysis and literature review
por: Yan, Wei, et al.
Publicado: (2016)

Hypermethylation status of DAPK, MGMT and RUNX3 in HPV negative oral and oropharyngeal squamous cell carcinoma
por: dos Reis, Raquel Silva, et al.
Publicado: (2020)

The prognostic value of CDKN2A hypermethylation in colorectal cancer: a meta-analysis
por: Xing, X, et al.
Publicado: (2013)

Discovery and Validation of Hypermethylated Markers for Colorectal Cancer
por: Wei, Jiufeng, et al.
Publicado: (2016)

The clinicopathological significance of hMLH1 hypermethylation in non-small-cell lung cancer: a meta-analysis and literature review
por: Han, Yi, et al.
Publicado: (2016)

No SMAD4 hypermethylation in colorectal cancer
por: Roth, S, et al.
Publicado: (2000)

Clinicopathological and prognostic significance of CDH1 hypermethylation in hepatocellular carcinoma: a meta-analysis
por: Wu, Xiaoyu, et al.
Publicado: (2019)

Clinicopathological significance of WIF1 hypermethylation in NSCLC, a meta-analysis and literature review
por: Guo, Hao, et al.
Publicado: (2016)

Downregulation of ADAMTS8 by DNA Hypermethylation in Gastric Cancer and Its Clinical Significance
por: Chen, Jing, et al.
Publicado: (2016)

Hypermethylation of heparanase 2 promotes colorectal cancer proliferation and is associated with poor prognosis
por: Zhang, Hui, et al.
Publicado: (2021)

Downregulation of SM22α protein by hypermethylation of its promoter in colorectal cancer
por: Liu, Yabin, et al.
Publicado: (2018)

APC hypermethylation for early diagnosis of colorectal cancer: a meta-analysis and literature review
por: Liang, Tie-Jun, et al.
Publicado: (2017)

Clinicopathological significance of the p16 hypermethylation in multiple myeloma, a systematic review and meta-analysis
por: Yu, Huiqing, et al.
Publicado: (2017)

DNA hypermethylation appears early and shows increased frequency with dysplasia in Lynch syndrome-associated colorectal adenomas and carcinomas
por: Valo, Satu, et al.
Publicado: (2015)

Epigenetic inactivation of RUNX3 in colorectal cancer
por: Shin, Eung Jin, et al.
Publicado: (2018)

Clinical significance of promoter region hypermethylation of microRNA-148a in gastrointestinal cancers
por: Sun, Jingxu, et al.
Publicado: (2014)

PCDH8 is Frequently Inactivated by Promoter Hypermethylation in Liver Cancer: Diagnostic and Clinical Significance
por: Zhang, Cheng, et al.
Publicado: (2016)

The clinical significance of HOXA9 promoter hypermethylation in head and neck squamous cell carcinoma
por: Zhou, Chongchang, et al.
Publicado: (2019)

Hypermethylation of EDNRB promoter contributes to the risk of colorectal cancer
por: Chen, Cheng, et al.
Publicado: (2013)

SCTR hypermethylation is a diagnostic biomarker in colorectal cancer
por: Li, DaPeng, et al.
Publicado: (2020)

Prognostic significance of CDH13 hypermethylation and mRNA in NSCLC
por: Xue, Ruilin, et al.
Publicado: (2014)

The diagnostic and prognostic value of CHFR hypermethylation in colorectal cancer, a meta-analysis and literature review
por: Sun, Zhulei, et al.
Publicado: (2017)

Clinicopathological significance and potential drug target of RUNX3 in breast cancer
por: Yu, Ying-Ying, et al.
Publicado: (2014)

Significant Pattern of Promoter Hypermethylation of UNC5C Gene in Colorectal Cancer and Its Implication in Late Stage Disease
por: Guroo, Sartaj A, et al.
Publicado: (2018)

Significance of Hypermethylation of Tumor-Suppressor Genes PTGER4 and ZNF43 at CpG Sites in the Prognosis of Colorectal Cancer
por: Chen, Chao-Yang, et al.
Publicado: (2022)

The clinicopathological significance and ethnic difference of FHIT hypermethylation in non-small-cell lung carcinoma: a meta-analysis and literature review
por: Wu, Xiaoyu, et al.
Publicado: (2016)

The Prognostic Value of p16 Hypermethylation in Cancer: A Meta-Analysis
por: Xing, Xiang-Bin, et al.
Publicado: (2013)

Hypermethylation of BEND5 contributes to cell proliferation and is a prognostic marker of colorectal cancer
por: Lin, Ruo-Kai, et al.
Publicado: (2017)

DNA hypermethylation in the normal colonic mucosa of patients with colorectal cancer
por: Kawakami, K, et al.
Publicado: (2006)

SMAD4 Promoter Hypermethylation in Kashmiri Colorectal Cancer Cases
por: Sameer, Aga S., et al.
Publicado: (2011)

The prognostic efficacy of cell-free DNA hypermethylation in colorectal cancer
por: Rasmussen, Simon Ladefoged, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_03h517opfhepslcduidcq0ugio